InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: IonStock post# 30142

Tuesday, 11/10/2020 3:03:06 PM

Tuesday, November 10, 2020 3:03:06 PM

Post# of 44690
There are several polls out showing less than 50% will take a vaccine as soon as it is available. Most have said that they would wait for Trials to move further or until people can see an obvious advantage to taking them like the yearly 'flu shots',
The Pfizer CEO said they will have a total of 50M doses in 2020 split Worldwide. Thats about 12M vaccinated in the US. 1B+ doses could be available by 2022. Cant find a price.
Of course some mAbs will be produced at their extreme high costs too. Rem will be around as it is being favored now as a SOC by the FDA. I still cant find info of any great success from Rem as compared to other SOC W/O Rem.
Doesnt 50% seem like a good base target for success?
Only a couple Drugs will be presenting data this year for Treatments and the EUA from the FDA that's needed here to start marketing. Both I know of are repurposed drugs with a Good Safety record. That puts them way ahead in this Race to be a contributor to the Fight against the effects of COVID.
I would say Prevention drugs/treatments/vaccines will be a next step but require huge populations to prove effectiveness and time to be accepted and produced for the general populations.
Billions of people may want a vaccine, eventually, and 50 Million were infected world wide so far.